Patent · US Active

Dual specific antibodies

US10683348B2 · kind B2 · utility

3Cited by
1References
15Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 27, 2016
Grant dateJun 16, 2020
Priority date
Expiry dateMay 27, 2036

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC07K2317/92
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The invention provides dual specific antibodies and methods of making and using such antibodies. In general, the dual specific antibodies are generated by identification of a monospecific antibody having light chain variable region VL residues that are electrostatic or hydrophobic and altering the nucleic acid sequence encoding one or more solvent accessible residues in the VH of the antibody either alone or in combination with alteration of the nucleic acid sequence encoding the VL of the antibody. The altered VH and the VL are expressed and dual specific antibodies, or antigen-binding fragments thereof, are selected. Exemplary dual specific antibodies are also provided as well as methods of using the antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.